Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
3/25/2008
 
First Published:
5/1/1998
1.
Phase III Randomized Study of Methylphenidate for Alleviation of Fatigue and Lethargy in Cancer Patients Receiving Interferon alfa
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Completed
18 and over
NCI
E-2Z96
NCI-P98-0130, NCT00003266
Last Modified:
2/4/2008
 
First Published:
3/1/2002
2.
Phase III Randomized Study of d-Methylphenidate to Improve Quality of Life in Patients Receiving Radiotherapy for Primary or Metastatic Brain Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Closed
18 and over
NCI
CCCWFU-97600
NCI-P02-0211, NCT00031798
Last Modified:
8/1/1990
3.
Phase III Placebo-Controlled Trial of Methylphenidate plus Narcotic to Manage Pain in Patients with Cancer (Summary Last Modified 08/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
8 and over
NCI
NCCTG-899251
MAYO-899251, NCI-P90-0007
Last Modified:
8/14/2008
 
First Published:
9/10/2006
4.
Phase III Randomized Study of Long-Acting Methylphenidate in Patients With Cancer-Related Fatigue
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
18 and over
NCI
NCCTG-N05C7
NCCTG N05C7, N05C7, NCT00376675
Last Modified:
10/6/2008
 
First Published:
9/24/2003
5.
Phase II Randomized Study of Dextroamphetamine-Amphetamine Versus Methylphenidate in Pediatric Cancer Patients With Treatment-Related Neurocognitive Sequelae and Depression
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Completed
6 to 17
NCI
MCC-0201
NCI-5899, HLMCC 0201, NCT00069927
6.
Psychostimulants for Fatigue in Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Completed
18 and over
Other
02-100
NCT00138138
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute